Aligos Therapeutics Inc
NASDAQ:ALGS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aligos Therapeutics Inc
NASDAQ:ALGS
|
US |
|
M
|
Marble Financial Inc
CNSX:MRBL
|
CA |
|
L
|
L'Oreal SA
F:LOR
|
FR |
|
Keysight Technologies Inc
NYSE:KEYS
|
US |
|
I
|
Imax Corp
XBER:IMA
|
CA |
|
Berry Corporation (Bry)
NASDAQ:BRY
|
US |
|
Medallion Financial Corp
NASDAQ:MFIN
|
US |
|
M
|
Mettler-Toledo International Inc
F:MTO
|
US |
|
Pact Group Holdings Ltd
ASX:PGH
|
AU |
|
I
|
Interlink Communication PCL
SET:ILINK
|
TH |
|
Affirm Holdings Inc
NASDAQ:AFRM
|
US |
|
United Tractors Tbk PT
IDX:UNTR
|
ID |
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
C
|
Calibre Mining Corp
F:WCLA
|
CA |
|
A
|
Alstom SA
DUS:AOMD
|
FR |
|
Penske Automotive Group Inc
F:UA9
|
US |
|
P
|
Pakuwon Jati Tbk PT
F:P04
|
ID |
|
B
|
Brunello Cucinelli SpA
XMUN:8BU
|
IT |
|
RHB Bank Bhd
KLSE:RHBBANK
|
MY |
|
3
|
3i Group PLC
F:IGQ5
|
UK |
|
S
|
Sula Vineyards Ltd
BSE:543711
|
IN |
|
I
|
ITV PLC
F:IJ7
|
UK |
|
H
|
H World Group Ltd
SWB:CL4A
|
CN |
|
D
|
Denso Corp
XMUN:DNO
|
JP |
Wall St Price Targets
ALGS Price Targets Summary
Aligos Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
ALGS is 39.27 USD with a low forecast of 20.2 USD and a high forecast of 52.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ALGS's stock price target?
Price Target
39.27
USD
According to Wall Street analysts, the average 1-year price target for
ALGS is 39.27 USD with a low forecast of 20.2 USD and a high forecast of 52.5 USD.
What is the Revenue forecast for Aligos Therapeutics Inc?
Projected CAGR
118%
The compound annual growth rate for Revenue over the next 8 years is 118%.